ASH 2021 – AbbVie VENCLEXTA Data
Dr. Jalaja Potluri, Executive Medical Director at AbbVie and the Development Leader for VENCLEXTA (venetoclax) discusses data on VENCLEXTA reinforcing the efficacy and versatility of this treatment in numerous blood cancers, including acute myeloid leukemia (AML)(abstract 1271), myelodysplastic syndrome (MDS)(abstract 537), and chronic lymphocytic leukemia (CLL). These data were presented at the 2021 American Society of Hematology (ASH) Annual Meeting. Visit www.hematology.org to learn more.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Jalaja Potluri is an Executive Medical Director at AbbVie and the Development Leader for VENCLEXTA (venetoclax). Dr. Potluri is a hematologist and medical oncologist focused on developing transformational treatments for patients with blood cancers. She has developed and conducted several studies that led to VENCLEXTA’s FDA approvals in chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Prior to joining the VENCLEXTA clinical development team in 2013, Dr. Potluri was a faculty member at the University of Illinois and at the Advocate Health Centers, where she had been involved in national co-operative oncology trials in blood cancers and was the director of the cancer committee. Dr. Potluri completed her M.D. at Nagarjuna University in India, and fellowship training in Hematology and Medical Oncology at the Medical College of Wisconsin.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
